Skip to content

Clinical Observation on Treatment of Carotid Artery Atherosclerosis with Gualou Xiebai Banxia Decoction and Hongqu

Clinical Observation on Treatment of Carotid Artery Atherosclerosis with Gualou Xiebai Banxia Decoction and Hongqu

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16009944
Enrollment
Unknown
Registered
2016-11-21
Start date
2017-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carotid Artery Atherosclerosis

Interventions

treatment group:Gualou Xiebai Banxia Decoction and Hongqu

Sponsors

Shanghai University of Traditional Chinese Medicine affiliated Yueyang hospital ethics committee
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) In line with diagnostic of carotid atherosclerosis in outpatient and ward patients; (2) In line with Chinese medicine diagnostic criteria of phlegm and blood stasis in both resistance; (3) Age 18-75 years old, gender is not limited; (4) willing to participate and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Do not meet the diagnostic criteria; 2. Pregnancy, breastfeeding women or not taking effective contraceptive measures of women of childbearing age; 3. With allergy history of drug which is used in this research; 4. Subjects with hemoglobin <90 g/L or platelets <100 x 10^9/L or leukocytes <3.0 x 10^9/L; 5. Combined with acute cardiovascular and cerebrovascular, liver, kidney and hematopoietic system and other serious diseases 6. Severe neurosis, menopausal syndrome, hyperthyroidism, cervical spondylosis, biliary-heart syndrome, stomach and esophageal reflux, esophageal hiatus hernia caused by chest pain; 7. With nervous system diseases and a history of mental trouble; 8. Active infection of the subjects; 9. Participating in other clinical drug research projects or subjects ending less than 3 months; 10. Subjects whose life expectancy is shorter than the duration of the trial; 11. Other conditions considered unsuitable for inclusion in the study.

Design outcomes

Primary

MeasureTime frame
Carotid Artery intima media thickness and plaque area;

Countries

China

Contacts

Public ContactFan min

Yueyang Hospital, Shanghai University of Traditional Chinese Medicine, 110 Ganhe Road, Shanghai, China

fanmin@medmail.com.cn+86 13564528699

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026